NEW YORK (GenomeWeb News) – Akonni Biosystems has raised about $935,000 of a targeted $20 million offering, the molecular diagnostics firm disclosed in a document filed with the US Securities and Exchange Commission.
The raise is in the form of equity, it said. The company said three investors participated in the round but did not identify them. It also did not provide an intended use of the proceeds and did not respond to a request for comment.
Based in Frederick, Md., Akonni develops, manufactures, and markets integrated molecular diagnostic systems. For the clinical markets, its lead platform is the Akonni TruDiagnosis system, which uses gel-drop microarrays. It also offers Akonni TruTip kits for extracting nucleic acids for the life science research market.
A year ago, the company said in an SEC filing that it was seeking to raise $8 million.